Trends of diagnosis and treatments of COVID-19

Basit Öğe Kaydı
dc.contributor.authorShaheen, Ibraheem Theeb
dc.contributor.authorKurdi, Yahya Nazem
dc.date.accessioned2024-07-12T21:58:33Z
dc.date.available2024-07-12T21:58:33Z
dc.date.issued2021en_US
dc.departmentMaltepe Üniversitesi, Rektörlüken_US
dc.description.abstractThe Coronavirus or SARS-CoV-2, is a highly pathogenic ?- coronavirus that infects humans through air transmission remotely. The most critical step in Early Diagnosis is to treat the infection. The Diagnostic methods include nasal swab, rectal swab recently used in China, Bronchio-alveolar leavage, chest x-ray, CT-san, Ultrasound, viral culture, serology, and molecular methods. CRISPR-based method is used to diagnose and treat the infection. Presence of IgG and IgM in blood examination [1]. Also a viral Gene detection, human antibody detection and viral antigen, amidst the viral gene detection by the RT-PCR is the most a ested technique [2]. Antiviral Inhibitors of the spike proteins of SARS and MERS, favipiravir, Azithromycin, antipyretics, ?- interferon, anticoagulants, anti-inflammatory drugs including corticosteroids and interleukins inhibitors, neuraminidase inhibitors and EK1 peptide are the therapeutic ways for SARS-CoV-2 infection. Hydroxychloroquine which was the treatment method for malaria has shown results in the SARS-CoV-2 treatment. Using and oxygen support can assuage the symptoms effectively [1]. A research was performed on the observation techniques and quantitative computable conviction methods of chloroquine and its related metabolites. Azithromycin is given with Hydroxychloroquine as a combination for treatment and anticoagulants for prevention of further complications [3]. The drugs hydroxychloroquine and chloroquine have antiviral characteristics immunologically in vitro. These findings show that these drugs have potency in treatment. But they have serious side effects, ranging from psychiatric to sudden death. So, favipiravir is the best drug of choice currently along with anticoagulants to prevent thrombosis [3][4].en_US
dc.identifier.citationShaheen, I.T. ve Kurdi, Y.N. (2021). Trends of diagnosis and treatments of COVID-19. International Faculty of Medical Sciences and Nursing(MEDNS) Student Congress , Maltepe Üniversitesi. s. 38-39.en_US
dc.identifier.endpage39en_US
dc.identifier.isbn978-605-2124-39-0
dc.identifier.startpage38en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12415/8823
dc.language.isoenen_US
dc.publisherMaltepe Üniversitesien_US
dc.relation.ispartofInternational Faculty of Medical Sciences and Nursing(MEDNS) Student Congressen_US
dc.relation.publicationcategoryUluslararası Konferans Öğesi - Başka Kurum Yazarıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKY08071
dc.subjectSARS-CoV-2 infectionen_US
dc.subjectImmunologyen_US
dc.subjectSARS-CoV-2 detectionen_US
dc.subjectHydroxychloroquineen_US
dc.subjectSARS-CoV-2 Diagnosis and Treatmenten_US
dc.titleTrends of diagnosis and treatments of COVID-19en_US
dc.typeConference Object
dspace.entity.typePublication

Dosyalar

Koleksiyon

Rektörlük-Maltepe Üniversitesi Dergileri Koleksiyonu

We collect and process your personal information for the following purposes: Authentication, Preferences, Acknowledgement and Statistics.
To learn more, please read our privacy policy.

Customize